Millipore Sigma Vibrant Logo

47589 Mitomycin C, Streptomyces caespitosus - CAS 50-07-7 - Calbiochem

Antibiotic and carcinostatic agent. Inhibits DNA synthesis by cross-linking DNA at guanine and adenine residues; disrupts base pairing.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Mitocin C, MMC

47589
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      50-07-7C₁₅H₁₈N₄O₅
      Description
      Overview

      This product has been discontinued.



      Antibiotic and carcinostatic agent. Inhibits DNA synthesis by cross-linking DNA at guanine and adenine residues; disrupts base pairing. Forms covalent adducts into deoxyguanine and guanine under acidic conditions. Induces apoptosis in gastric cancer cells. Blocks the cell cycle at the G2 phase.
      Catalogue Number47589
      Brand Family Calbiochem®
      SynonymsMitocin C, MMC
      References
      ReferencesKruyt, F.A., et al. 1996. Blood 89, 938.
      Schwartz, G.K., et al. 1995. J. Natl. Cancer Inst. 87, 1394.
      Folnan, R.S. 1993. Oncology 50 (Suppl. 1), 24.
      Kawasaki, S., et al. 1992. Jpn. J. Cancer Res. 83, 899.
      Malkinson, A.M., et al. 1992. Cancer Res. 52, 4752.
      McEvoy, J.L., et al. 1992. J. Bacteriol. 174, 5471.
      Tomasz, M., et al. 1987. Science 235, 1204.
      Product Information
      CAS number50-07-7
      FormBlue-violet solid
      FormulationProvided as 2 mg antibiotic and 48 mg NaCl.
      Hill FormulaC₁₅H₁₈N₄O₅
      Chemical formulaC₁₅H₁₈N₄O₅
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSCN0700000
      Safety Information
      R PhraseR: 28

      Very toxic if swallowed.
      S PhraseS: 36/37-45-28

      Wear suitable protective clothing and gloves.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C) for short-term storage and in a freezer (-20°C) for longer term. Stock solutions are stable for up to 2 weeks at 4°C and up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      47589 0

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Mitomycin C, Streptomyces caespitosus - CAS 50-07-7 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Mitomycin C, Streptomyces caespitosus - CAS 50-07-7 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      47589

      Références bibliographiques

      Aperçu de la référence bibliographique
      Kruyt, F.A., et al. 1996. Blood 89, 938.
      Schwartz, G.K., et al. 1995. J. Natl. Cancer Inst. 87, 1394.
      Folnan, R.S. 1993. Oncology 50 (Suppl. 1), 24.
      Kawasaki, S., et al. 1992. Jpn. J. Cancer Res. 83, 899.
      Malkinson, A.M., et al. 1992. Cancer Res. 52, 4752.
      McEvoy, J.L., et al. 1992. J. Bacteriol. 174, 5471.
      Tomasz, M., et al. 1987. Science 235, 1204.

      Brochure

      Titre
      Caspases and other Apoptosis Related Tools Brochure
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-May-2008 RFH
      SynonymsMitocin C, MMC
      DescriptionAntibiotic and carcinostatic agent. Inhibits DNA synthesis by cross-linking DNA at guanine and adenine residues, disrupting base pairing. Induces apoptosis in gastic cancer cells. Blocks the cell cycle at the G2 phase.
      FormBlue-violet solid
      FormulationProvided as 2 mg antibiotic and 48 mg NaCl.
      CAS number50-07-7
      RTECSCN0700000
      Chemical formulaC₁₅H₁₈N₄O₅
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityH₂O (1 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C) for short-term storage and in a freezer (-20°C) for longer term. Stock solutions are stable for up to 2 weeks at 4°C and up to 3 months at -20°C.
      Toxicity Highly Toxic & Carcinogenic / Teratogenic
      Merck USA index14, 6215
      ReferencesKruyt, F.A., et al. 1996. Blood 89, 938.
      Schwartz, G.K., et al. 1995. J. Natl. Cancer Inst. 87, 1394.
      Folnan, R.S. 1993. Oncology 50 (Suppl. 1), 24.
      Kawasaki, S., et al. 1992. Jpn. J. Cancer Res. 83, 899.
      Malkinson, A.M., et al. 1992. Cancer Res. 52, 4752.
      McEvoy, J.L., et al. 1992. J. Bacteriol. 174, 5471.
      Tomasz, M., et al. 1987. Science 235, 1204.